Open AccessSafety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma
Author(s) -
Tania Jain,
Craig S. Sauter,
Gunjan L. Shah,
Molly Maloy,
Jason E. Chan,
Michael Scordo,
Scott T. Avecilla,
Yakup Batlevi,
Parastoo B. Dahi,
Connie W Batlevi,
M. Lia Palomba,
Sergío Giralt,
MiguelAngel Perales
Publication year - 2019
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-019-0476-y
Subject(s) - chimeric antigen receptor , hematopoietic cell , lymphoma , refractory (planetary science) , transplantation , hematopoietic stem cell transplantation , medicine , immunology , haematopoiesis , antigen , cancer research , oncology , stem cell , t cell , biology , immune system , astrobiology , genetics